Resources

Find a Clinical Trial

Clinical trials may offer additional treatment options for people with lung cancer. Exploring trials early — before treatment begins — can help ensure you and your care team are aware of all available choices.

Before You Start Your Search

Eligibility for clinical trials depends on factors such as cancer type, stage, prior treatment, and overall health.

Before you begin, it helps to have a few details available. This can make your search results more accurate and easier to discuss with your care team.

Helpful information to gather:

  • Your lung cancer type (for example: NSCLC or SCLC) and stage
  • Any treatments you’ve already received (if any)
  • Whether you’ve had biomarker or genetic testing
  • Recent scan results (CT, PET, MRI) and pathology details
  • Your general health and any major medical conditions

 

Tip: If you’re newly diagnosed, ask your doctor:
“Are there clinical trials I should consider before starting treatment?”

Examples of Lung Cancer Clinical Trials

There are different types of studies patients may encounter.

Studies evaluating whether adding immunotherapy to standard chemotherapy improves outcomes for certain types of lung cancer, including extensive-stage small cell lung cancer.

Trials studying treatments designed for cancers with specific genetic or molecular features.

Studies examining whether continued treatment after initial therapy helps control cancer longer.

Not sure where to start?

Take these tools with you to your next appointment.

  • Questions to Ask Your Doctor About Clinical Trials
  • What Happens in a Clinical Trial?
  • Clinical Trials 101
This field is for validation purposes and should be left unchanged.
Name(Required)

Featured Trial Category:
Extensive-Stage SCLC Research

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

A randomized phase 3 trial in first‑line extensive‑stage small‑cell lung cancer of BNT327 in combination with chemotherapy>

Trial status: Recruiting | Trial Identifier: BNT327-03 | ClinicalTrials.gov Identifier: NCT06712355

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (EVOKE-SCLC-04)

Trial status: Recruiting | Trial Identifier: GS-US-600-6165 | ClinicalTrials.gov ID NCT06801834